Cytochalasin Z16 reshapes macrophage responses to intracellular pathogens: HSPA5-targeted immunotherapy against zoonotic and foodborne Edwardsiella tarda.

Fuente: PubMed
Salvato in:
Dettagli Bibliografici
Autori principali: Shi, Jin-Jin, Yu, Jing, Wang, Ran, Zhao, Hang, Su, Yu-Qi, Liu, Yan-Jun, Chen, Ru-Yi, Ding, Li-Jian, Yang, Guan-Jun, Chen, Jiong
Natura: Artículo científico
Lingua:en
Pubblicazione: International immunopharmacology 2026
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1868266097698930690
author Shi, Jin-Jin
Yu, Jing
Wang, Ran
Zhao, Hang
Su, Yu-Qi
Liu, Yan-Jun
Chen, Ru-Yi
Ding, Li-Jian
Yang, Guan-Jun
Chen, Jiong
author_facet Shi, Jin-Jin
Yu, Jing
Wang, Ran
Zhao, Hang
Su, Yu-Qi
Liu, Yan-Jun
Chen, Ru-Yi
Ding, Li-Jian
Yang, Guan-Jun
Chen, Jiong
Shi, Jin-Jin
Yu, Jing
Wang, Ran
Zhao, Hang
Su, Yu-Qi
Liu, Yan-Jun
Chen, Ru-Yi
Ding, Li-Jian
Yang, Guan-Jun
Chen, Jiong
collection PubMed - marine biology
contents Cytochalasin Z16 reshapes macrophage responses to intracellular pathogens: HSPA5-targeted immunotherapy against zoonotic and foodborne Edwardsiella tarda. Shi, Jin-Jin Yu, Jing Wang, Ran Zhao, Hang Su, Yu-Qi Liu, Yan-Jun Chen, Ru-Yi Ding, Li-Jian Yang, Guan-Jun Chen, Jiong Edwardsiella tarda Animals Humans Macrophages Endoplasmic Reticulum Chaperone BiP Cytochalasins Phagocytosis Heat-Shock Proteins Enterobacteriaceae Infections Immunotherapy Host-Directed Therapy Reactive Oxygen Species Apoptosis Foodborne Diseases Edwardsiella tarda is a zoonotic, foodborne intracellular pathogen that causes significant disease in both farmed and wild fish and can also infect humans. By surviving within macrophages, this pathogen evades immune clearance, presenting a challenge for treatment. Compound 5, a marine fungal macrocyclic lactone structurally classified among anti-inflammatory cytochalasins (formerly cytochalasin Z16) and isolated from the marine-derived fungus Aspergillus sp. NBU4698, lacks direct antibacterial activity but markedly enhances macrophage-mediated clearance of E. tarda. This compound exerts multifaceted immunomodulatory effects: it suppresses phagocytosis, pathogen-induced apoptosis, and inflammation while simultaneously promoting bacterial killing. These actions occur through dual regulation of ROS-elevating mitochondrial ROS while reducing total cellular ROS-and via modulation of the lipid droplet-antimicrobial peptide axis, which inhibits E. tarda-stimulated lipid droplet formation and CRAMP expression. Mechanistically, compound 5 targets HSPA5, a protein that appears to coordinate host defense through interactions with alpha-2-macroglobulin (A2M) and siah E3 ubiquitin protein ligase 2 (SIAH2). Our findings identify HSPA5 as a promising target for host-directed therapy and provide the first evidence for cytochalasin-based immunomodulation against intracellular bacterial pathogens.
format Artículo científico
id pubmed_41554224
institution PubMed
language en
publishDate 2026
publisher International immunopharmacology
record_format pubmed
spellingShingle Cytochalasin Z16 reshapes macrophage responses to intracellular pathogens: HSPA5-targeted immunotherapy against zoonotic and foodborne Edwardsiella tarda.
Shi, Jin-Jin
Yu, Jing
Wang, Ran
Zhao, Hang
Su, Yu-Qi
Liu, Yan-Jun
Chen, Ru-Yi
Ding, Li-Jian
Yang, Guan-Jun
Chen, Jiong
Edwardsiella tarda
Animals
Humans
Macrophages
Endoplasmic Reticulum Chaperone BiP
Cytochalasins
Phagocytosis
Heat-Shock Proteins
Enterobacteriaceae Infections
Immunotherapy
Host-Directed Therapy
Reactive Oxygen Species
Apoptosis
Foodborne Diseases
Cytochalasin Z16 reshapes macrophage responses to intracellular pathogens: HSPA5-targeted immunotherapy against zoonotic and foodborne Edwardsiella tarda. Shi, Jin-Jin Yu, Jing Wang, Ran Zhao, Hang Su, Yu-Qi Liu, Yan-Jun Chen, Ru-Yi Ding, Li-Jian Yang, Guan-Jun Chen, Jiong Edwardsiella tarda Animals Humans Macrophages Endoplasmic Reticulum Chaperone BiP Cytochalasins Phagocytosis Heat-Shock Proteins Enterobacteriaceae Infections Immunotherapy Host-Directed Therapy Reactive Oxygen Species Apoptosis Foodborne Diseases Edwardsiella tarda is a zoonotic, foodborne intracellular pathogen that causes significant disease in both farmed and wild fish and can also infect humans. By surviving within macrophages, this pathogen evades immune clearance, presenting a challenge for treatment. Compound 5, a marine fungal macrocyclic lactone structurally classified among anti-inflammatory cytochalasins (formerly cytochalasin Z16) and isolated from the marine-derived fungus Aspergillus sp. NBU4698, lacks direct antibacterial activity but markedly enhances macrophage-mediated clearance of E. tarda. This compound exerts multifaceted immunomodulatory effects: it suppresses phagocytosis, pathogen-induced apoptosis, and inflammation while simultaneously promoting bacterial killing. These actions occur through dual regulation of ROS-elevating mitochondrial ROS while reducing total cellular ROS-and via modulation of the lipid droplet-antimicrobial peptide axis, which inhibits E. tarda-stimulated lipid droplet formation and CRAMP expression. Mechanistically, compound 5 targets HSPA5, a protein that appears to coordinate host defense through interactions with alpha-2-macroglobulin (A2M) and siah E3 ubiquitin protein ligase 2 (SIAH2). Our findings identify HSPA5 as a promising target for host-directed therapy and provide the first evidence for cytochalasin-based immunomodulation against intracellular bacterial pathogens.
title Cytochalasin Z16 reshapes macrophage responses to intracellular pathogens: HSPA5-targeted immunotherapy against zoonotic and foodborne Edwardsiella tarda.
topic Edwardsiella tarda
Animals
Humans
Macrophages
Endoplasmic Reticulum Chaperone BiP
Cytochalasins
Phagocytosis
Heat-Shock Proteins
Enterobacteriaceae Infections
Immunotherapy
Host-Directed Therapy
Reactive Oxygen Species
Apoptosis
Foodborne Diseases
url https://pubmed.ncbi.nlm.nih.gov/41554224/